
FDA Approves First Orexin-Targeting Drug for Narcolepsy Type 1
<a href="https://news.google.com/rss/articles/CBMixgFBVV95cUxNN3I2SUJTSE9jNWtncFZ6ZVFpMzRTbzM3MHh5WGxCeGhkVlF5QkhEQWZNVVFLMS12LVg3U1dJTE5zV3RtRnpFaG9ON0JCQkxTQjNqT2dNQlZGeC1welU2aWMyR2FzTGJzQlpCaVJEblMtMTBHWVJncWM3SjE2cEtpYU9Eb3A4eUZkUExZemtfano4WFp6aS1SbkdaMm1lU2ltaHdiWm1UcC1vSS1GTUdOZE9KNFJWYzQ2R2Ruc2IxTW80YXJyU2c?oc=5" target="_blank">FDA Approves First Orexin-Targeting Drug for Narcolepsy Type 1</a>&nbsp;&nbsp;<font color="#6f6f6f">Sleep Review</font>
